Grid Dynamics Holdings, Inc. GDYN Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| CPG/Manufacturing | $9.76M-9.4% | $10.77M-4.3% | $10.91M+11.3% | $10.6M+7.7% | $10.77M+12.7% | |
| Finance | $24.45M-2.3% | $24.35M+5.0% | $25.62M+81.0% | $25.39M+102% | $25.03M+144% | |
| Healthcare and Pharma | $2.15M-10.4% | $2.8M+15.1% | $2.42M-3.5% | $2.56M-19.1% | $2.41M-20.1% | |
| Retail | $29.57M-6.2% | $30.48M-6.9% | $28.95M-2.9% | $29.56M+10.4% | $31.52M+28.0% | |
| Technology, Media and Telecom | $30.76M+30.3% | $30.08M+27.5% | $28.58M+18.2% | $25.19M+8.4% | $23.6M-1.8% | |
| Revenue by Geography | ||||||
| Europe | $24.63M+29.9% | $23.78M+18.6% | $22.83M+103% | $20.86M+79.7% | $18.96M+41.5% | |
| India | $4.01M+76.0% | —— | $3.96M+339% | $3.28M+2,130% | $2.28M— | |
| North America | $71.02M-2.3% | $73.66M+1.3% | $71.93M-2.0% | $71.09M+2.5% | $72.68M+14.0% | |
| Other | $12.78M+12.0% | $27.02M+83.1% | $12.92M+51.4% | $12.14M+37.3% | $11.42M+14.8% | |
| Poland | $3.64M+8.3% | $3.46M+4.2% | $3.65M+266% | $3.53M+302% | $3.36M+296% | |
| United Kingdom | $12.74M+18.9% | $11.66M+1.3% | $11.72M+189% | $11.11M+164% | $10.72M+94.5% | |
| United States | $70.93M-2.4% | $73.53M+1.7% | $71.93M-1.4% | $71.04M+3.0% | $72.64M+14.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Grid Dynamics Holdings, Inc. break its business down?
- Grid Dynamics Holdings, Inc. (GDYN) reports revenue by product across 5 parts — CPG/Manufacturing, Finance, Healthcare and Pharma, Retail and Technology, Media and Telecom. Each is extracted from the segment footnotes and tracked over time.
- Where does Grid Dynamics Holdings, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Grid Dynamics Holdings, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
